Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedFeb 28, 2024
DataAggregated Company Financials
Companies87
  • 7D0.6%
  • 3M24.3%
  • 1Y12.4%
  • YTDn/a

Over the last 7 days, the Pharma industry has risen 3.2%, driven by gains from Trulieve Cannabis of 15%. This takes the industry's 12 month performance to a gain of 14%. As for the next few years, earnings are expected to grow by 69% per annum.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 Feb 2024CA$22.5bCA$12.0b-CA$4,641,679,672.269.4x-4.8x1.9x
Fri, 26 Jan 2024CA$22.0bCA$12.4b-CA$6,757,492,735.009.6x-3.3x1.8x
Sun, 24 Dec 2023CA$17.0bCA$12.2b-CA$6,714,594,490.008.6x-2.5x1.4x
Tue, 21 Nov 2023CA$18.0bCA$12.5b-CA$6,837,915,349.007.1x-2.6x1.4x
Thu, 19 Oct 2023CA$17.6bCA$12.4b-CA$7,347,425,067.0012.7x-2.4x1.4x
Sat, 16 Sep 2023CA$21.7bCA$12.9b-CA$7,891,240,783.0015.1x-2.7x1.7x
Mon, 14 Aug 2023CA$14.2bCA$13.1b-CA$8,047,889,373.0011.9x-1.8x1.1x
Wed, 12 Jul 2023CA$16.5bCA$13.2b-CA$9,510,605,286.0012.7x-1.7x1.3x
Fri, 09 Jun 2023CA$14.8bCA$13.3b-CA$10,393,105,221.0010x-1.4x1.1x
Sun, 07 May 2023CA$16.5bCA$13.2b-CA$10,202,319,107.0011.1x-1.6x1.3x
Tue, 04 Apr 2023CA$15.9bCA$13.3b-CA$10,013,748,891.009.1x-1.6x1.2x
Thu, 02 Mar 2023CA$19.2bCA$13.7b-CA$10,328,538,403.009.8x-1.9x1.4x
Sat, 28 Jan 2023CA$19.4bCA$13.5b-CA$10,086,719,769.0014.3x-1.9x1.4x
Mon, 26 Dec 2022CA$20.1bCA$13.6b-CA$10,141,873,707.0013.4x-2x1.5x
Wed, 23 Nov 2022CA$29.1bCA$13.4b-CA$10,210,433,727.0010.4x-2.9x2.2x
Fri, 21 Oct 2022CA$28.5bCA$13.5b-CA$9,417,804,777.0011.4x-3x2.1x
Sun, 18 Sep 2022CA$28.4bCA$13.1b-CA$8,843,772,737.0013.7x-3.2x2.2x
Tue, 16 Aug 2022CA$29.9bCA$12.6b-CA$8,224,418,726.0015.5x-3.6x2.4x
Thu, 14 Jul 2022CA$25.9bCA$12.2b-CA$5,770,914,823.0011x-4.5x2.1x
Sat, 11 Jun 2022CA$30.6bCA$12.3b-CA$5,521,135,477.009.7x-5.5x2.5x
Mon, 09 May 2022CA$34.7bCA$12.0b-CA$4,925,777,728.0011.6x-7x2.9x
Wed, 06 Apr 2022CA$43.7bCA$11.6b-CA$4,637,599,726.0013.3x-9.4x3.8x
Fri, 04 Mar 2022CA$42.0bCA$10.6b-CA$4,397,055,257.0013.4x-9.5x4x
Sun, 30 Jan 2022CA$44.4bCA$10.9b-CA$4,933,422,632.0011.6x-9x4.1x
Tue, 28 Dec 2021CA$54.9bCA$10.9b-CA$4,962,532,468.0013.6x-11.1x5x
Thu, 25 Nov 2021CA$66.3bCA$10.8b-CA$4,865,632,534.0020.3x-13.6x6.1x
Sat, 23 Oct 2021CA$61.5bCA$10.1b-CA$4,890,831,605.0018.8x-12.6x6.1x
Mon, 20 Sep 2021CA$66.8bCA$10.4b-CA$6,658,476,418.0021.4x-10x6.4x
Wed, 18 Aug 2021CA$69.6bCA$10.2b-CA$6,616,236,433.2722x-10.5x6.8x
Wed, 02 Jun 2021CA$81.6bCA$8.9b-CA$7,509,828,145.2124.4x-10.9x9.2x
Sat, 06 Mar 2021CA$92.2bCA$7.6b-CA$8,166,561,132.2744.4x-11.3x12.2x
Price to Earnings Ratio

-11.3x


Total Market Cap: CA$92.2bTotal Earnings: -CA$8,166,561,132.27Total Revenue: CA$7.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -5.9x202220232024
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.7x is higher than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Canadian Pharma compare with similar industries?

CA Market0.75%
Healthcare1.09%
Pharma0.56%
Pharma0.56%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TRUL Trulieve CannabisCA$13.169.7%
+CA$216.1m
55.0%PS1.6x
CRON Cronos GroupCA$3.134.7%
+CA$53.4m
7.9%PS9.7x
TSND TerrAscendCA$2.357.8%
+CA$49.5m
8.3%PS1.7x
AYR.A Ayr WellnessCA$3.0014.1%
+CA$41.6m
104.1%PS0.5x
CL Cresco LabsCA$2.404.8%
+CA$38.3m
1.3%PS0.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IAN

CA$0.03

iAnthus Capital Holdings

7D

20.0%

1Y

0%

AYR.A

CA$3.00

Ayr Wellness

7D

14.1%

1Y

104.1%

TSND

CA$2.35

TerrAscend

7D

7.8%

1Y

8.3%

HUGE

CA$1.28

FSD Pharma

7D

-13.5%

1Y

-43.9%

CRDL

CA$2.32

Cardiol Therapeutics

7D

16.6%

1Y

226.8%

CXXI

CA$0.48

C21 Investments

7D

-9.4%

1Y

18.5%

OGI

CA$2.91

Organigram Holdings

7D

6.6%

1Y

-28.7%

CL

CA$2.40

Cresco Labs

7D

4.8%

1Y

1.3%

GTII

CA$17.60

Green Thumb Industries

7D

-1.8%

1Y

57.1%

VRNO

CA$7.44

Verano Holdings

7D

-5.6%

1Y

90.8%